Living Donor Liver Transplantation for Progressive Familial Intrahepatic Cholestasis Type 1: Two Reported Cases

Abstract Background Progressive familial intrahepatic cholestasis type 1 (PFIC1) is an inherited disease characterized by cholestatic features. We report two patients with PFIC1 who underwent liver retransplantation. Case Report One patient was a 3-year-old female who underwent liver transplantation...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2017-06, Vol.49 (5), p.1123-1125
Main Authors: Oya, Y, Sugawara, Y, Honda, M, Yoshii, D, Isono, K, Hayashida, S, Yamamoto, H, Inomata, Y
Format: Article
Language:English
Subjects:
Child, Preschool
Cholestasis, Intrahepatic - surgery
Fatty Liver - etiology
Female
Graft Rejection
Humans
Liver Cirrhosis - etiology
Liver Failure - etiology
Liver Transplantation - adverse effects
Liver Transplantation - mortality
Living Donors
Male
Reoperation - adverse effects
Reoperation - mortality
Surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Progressive familial intrahepatic cholestasis type 1 (PFIC1) is an inherited disease characterized by cholestatic features. We report two patients with PFIC1 who underwent liver retransplantation. Case Report One patient was a 3-year-old female who underwent liver transplantation for PFIC1. She presented with severe diarrhea and fatty liver, and went into liver failure. She therefore underwent liver retransplantation and external biliary diversion 8 years after the initial liver transplantation. The explanted liver was histologically diagnosed with chronic rejection. Her intractable diarrhea stopped after the retransplantation. She was diagnosed with a fatty liver 8 months after the retransplantation and died 4 years after retransplantation due to bleeding from an ileostomy. The other patient was a 3-year-old male. This patient underwent liver retransplantation due to liver cirrhosis caused by steatohepatitis 9 years after the initial liver transplantation. The biliary tract was not diverted. He also experienced severe diarrhea after the retransplantation and requires home parenteral nutrition due to an eating disorder. Conclusions Liver transplantation is the only treatment to resolve life-threatening issues due to PFIC1, but requires further improvement as a therapeutic modality.
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2017.03.035